2nd Circ. Questions Takeda's 'Lazarus' Take On Drug Patents
A Second Circuit panel grilled Takeda in oral arguments Wednesday on the pharmaceutical company's bid to duck antitrust claims that it delayed the entry of generic alternatives to diabetes treatment Actos,...To view the full article, register now.
Already a subscriber? Click here to view full article